Concepedia

Author

Jessica Filiatrault

Dana-Farber Cancer InstituteORCID

Also Known As

Jessica Filiatrault

23

Publications

151

Citations

7

H-Index

14

Concepts

All Affiliations

Dana-Farber Cancer InstituteUniversity of Pittsburgh Medical CenterInstituto Nacional de PediatriaOregon Health & Science UniversityMexican Social Security Institute
JF

About

Jessica Filiatrault is an author at Dana-Farber Cancer Institute specializing in cell biology, medicine, and developmental biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

103

2

Cell Biology

3

3

103

3

Health Sciences

1

1

64

4

Immunology

1

1

64

5

Cell Development

1

1

16

Jessica Filiatrault

×

6

Publications

140

Citations

6

H-Index

YearCitations

MYC Promotes Bone Marrow Stem Cell Dysfunction in Fanconi Anemia

Alfredo Rodríguez, Kaiyang Zhang, Anniina Färkkilä,

Cell stem cell

2020

64

Inhibition of TGFβ1 and TGFβ3 promotes hematopoiesis in Fanconi anemia

Alfredo Rodríguez, Chunyu Yang, Elissa Furutani,

Experimental Hematology

2020

23

TGFβ pathway is required for viable gestation of Fanconi anemia embryos

Alfredo Rodríguez, Michael W. Epperly, Jessica Filiatrault,

PLoS Genetics

2022

16

Deletion of the Fanconi Anemia C Gene in Mice Leads to Skeletal Anomalies and Defective Bone Mineralization and Microarchitecture

Mélody Mazon, Jacinthe Julien, Roth‐Visal Ung,

Journal of Bone and Mineral Research

2018

13

KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule Inhibitors

Yogesh K. Chutake, Michele Mayo, Nancy Dumont,

Molecular Cancer Therapeutics

2024

13

Development of KT-253, a Highly Potent and Selective Heterobifunctional MDM2 Degrader for the Treatment of Acute Myeloid Leukemia

Michele Mayo, Yogesh K. Chutake, Rahul Karnik,

Blood

2022

11

Page 1